These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15517079)

  • 1. Relationship between the prevalence of anti-glutamic acid decarboxylase autoantibodies and duration of type 1 diabetes mellitus in Brazilian patients.
    Rodacki M; Zajdenverg L; Albernaz MS; Bencke-Gonçalves MR; Milech A; Oliveira JE
    Braz J Med Biol Res; 2004 Nov; 37(11):1645-50. PubMed ID: 15517079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases.
    Lindholm E; Hallengren B; Agardh CD
    Diabetes Metab Res Rev; 2004; 20(2):158-64. PubMed ID: 15037992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GAD antibodies in T1D and LADA--relations to age, BMI, c-peptide, IA-2 and HLA-DRB1*03 and DRB1*04 alleles.
    Weber P; Ambrosova P; Canov P; Weberova D; Kuklinek P; Meluzinova H; Matejovska-Kubesova H; Cejkova P; Bielakova K; Cerna M
    Adv Gerontol; 2011; 24(2):312-8. PubMed ID: 21957594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and genetic characteristics of people with type 1 diabetes who have discrepancies in titers of anti-glutamic acid decarboxylase antibody measured by radioimmunoassay and enzyme-linked immunosorbent assay.
    Takagi S; Miura J; Hoshina S; Uchigata Y; Babazono T
    J Diabetes Investig; 2020 Mar; 11(2):356-362. PubMed ID: 31267698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics of anti-glutamic acid decarboxylase antibody-positive fulminant type 1 diabetes.
    Saito D; Oikawa Y; Mizutani G; Inoue K; Hatano M; Inoue I; Noda M; Shimada A
    Endocr J; 2019 Apr; 66(4):329-336. PubMed ID: 30760658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of age at diagnosis and duration of diabetes on the positivity of glutamic acid decarboxylase antibody in South-Brazilian type 1 diabetes mellitus.
    Maraschin Jde F; Weinert LS; Murussi N; Witter V; Rodrigues Tda C; Rossato ER; Silveiro SP
    Ann Clin Biochem; 2013 May; 50(Pt 3):262-6. PubMed ID: 23610212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrepancy of glutamic acid decarboxylase 65 autoantibody results between RSR radioimmunoassay and enzyme-linked immunosorbent assay in patients with type 1 diabetes is related to autoantibody affinity.
    Kawasaki E; Okada A; Uchida A; Fukuyama T; Sagara Y; Nakano Y; Tamai H; Tojikubo M; Koga N
    J Diabetes Investig; 2019 Jul; 10(4):990-996. PubMed ID: 30582775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of future insulin-deficiency in glutamic acid decarboxylase autoantibody enzyme-linked immunosorbent assay-positive patients with slowly-progressive type 1 diabetes.
    Kawasaki E; Awata T; Ikegami H; Imagawa A; Oikawa Y; Osawa H; Katsuki T; Kanatsuna N; Kawamura R; Kozawa J; Kodani N; Kobayashi T; Shimada A; Shimoda M; Takahashi K; Chujo D; Tsujimoto T; Tsuchiya K; Terakawa A; Terasaki J; Nagasawa K; Noso S; Fukui T; Horie I; Yasuda K; Yasuda H; Yanai H; Hanafusa T; Kajio H;
    J Diabetes Investig; 2024 Jul; 15(7):835-842. PubMed ID: 38451108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of islet autoimmunity in the aetiology of different clinical subtypes of diabetes mellitus in young north Indians.
    Singh AK; Bhatia E; Dabadghao P; Bhatia V; Gellert SA; Colman PG
    Diabet Med; 2000 Apr; 17(4):275-80. PubMed ID: 10821293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating anti-glutamic acid decarboxylase-65 antibody titers are positively associated with the capacity of insulin secretion in acute-onset type 1 diabetes with short duration in a Japanese population.
    Yamamura S; Fukui T; Mori Y; Hayashi T; Yamamoto T; Ohara M; Fukase A; Sasamori H; Kobayashi T; Hirano T
    J Diabetes Investig; 2019 Nov; 10(6):1480-1489. PubMed ID: 30919585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies to N-terminally Truncated GAD65(96-585): HLA Associations and Predictive Value for Type 1 Diabetes.
    Pöllänen PM; Härkönen T; Ilonen J; Toppari J; Veijola R; Siljander H; Knip M
    J Clin Endocrinol Metab; 2022 Feb; 107(3):e935-e946. PubMed ID: 34747488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between high titers of glutamic acid decarboxylase antibody and epilepsy in patients with type 1 diabetes mellitus: A cross-sectional study.
    Aguiar TS; Dantas JR; Cabral DB; Rêgo CCS; Zajdenverg L; Salles GF; Alves-Leon SV; Rodacki M; Lima MA
    Seizure; 2019 Oct; 71():318-321. PubMed ID: 31525611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies to N-terminally truncated GAD improve clinical phenotyping of individuals with adult-onset diabetes: Action LADA 12.
    Achenbach P; Hawa MI; Krause S; Lampasona V; Jerram ST; Williams AJK; Bonifacio E; Ziegler AG; Leslie RD;
    Diabetologia; 2018 Jul; 61(7):1644-1649. PubMed ID: 29619531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of early subclinical somatic neuropathy in children and adolescents with Type 1 diabetes mellitus and its association with the persistence of autoantibodies to glutamic acid decarboxylase (GAD) and islet antigen-2 (IA-2).
    Louraki M; Katsalouli M; Kanaka-Gantenbein C; Kafassi N; Critselis E; Kallinikou D; Tsentidis C; Karavanaki K
    Diabetes Res Clin Pract; 2016 Jul; 117():82-90. PubMed ID: 27329026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of in-vitro phenotypes of glutamic acid decarboxylase 65 autoantibodies in high-titre individuals.
    Chéramy M; Hampe CS; Ludvigsson J; Casas R
    Clin Exp Immunol; 2013 Mar; 171(3):247-54. PubMed ID: 23379430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 1 diabetes and epilepsy in childhood and adolescence: Do glutamic acid decarboxylase autoantibodies play a role? Data from the German/Austrian/Swiss/Luxembourgian DPV Registry.
    de Sousa GJ; Tittel SR; Häusler M; Holterhus PM; Berger G; Holder M; Kamrath C; Golembowski S; Herrlinger S; Holl RW
    Pediatr Diabetes; 2020 Aug; 21(5):766-773. PubMed ID: 32333480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Use of Electrochemiluminescence Assays to Predict Autoantibody and Glycemic Progression Toward Type 1 Diabetes in Individuals with Single Autoantibodies.
    Sosenko JM; Yu L; Skyler JS; Krischer JP; Gottlieb PA; Boulware D; Miao D; Palmer JP; Steck AK
    Diabetes Technol Ther; 2017 Mar; 19(3):183-187. PubMed ID: 28177779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamic acid decarboxylase 65 autoantibody levels discriminate two subtypes of latent autoimmune diabetes in adults.
    Li X; Yang L; Zhou Z; Huang G; Yan X
    Chin Med J (Engl); 2003 Nov; 116(11):1728-32. PubMed ID: 14642146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of IA-2 antibody in Japanese type 1 diabetes: its association with GAD antibody.
    Ota T; Takamura T; Nagai Y; Bando Y; Usuda R
    Diabetes Res Clin Pract; 2005 Jan; 67(1):63-9. PubMed ID: 15620435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between the prevalence of type 1 diabetes with the daily insulin dose and the autoimmune process against glutamic acid decarboxylase in adults.
    Khalangot M; Kravchenko V; Tronko M; Gur'ianov V
    Eur J Intern Med; 2009 Oct; 20(6):611-5. PubMed ID: 19782923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.